Skip to content

The clinical application of robotic-assisted three-port transoral endoscopic thyroidectomy vestibular approach

The clinical application of robotic-assisted three-port transoral endoscopic thyroidectomy vestibular approach

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300069021
Enrollment
Unknown
Registered
2023-03-03
Start date
2023-03-03
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid nodule

Interventions

robotic-assisted three-port transoral endoscopic thyroidectomy vestibular approach group:NA
Conventional transoral vestibuloscopic thyroid surgery group:N/A

Sponsors

Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) have reached the age of 18; (2) The maximum diameter of benign tumor was less than 6cm; (3) The maximum diameter of malignant tumor was less than 4cm; (4) Patients without parathyroid-related diseases; (5) No abnormalities were found in preoperative laryngoscopy; (6) Understand the research content and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Pregnant or lactating women; (2) Have a history of neck surgery or radiotherapy; (3) The patient is not suitable for surgery; (4) hyperthyroidism or depression; (5) transopening during endoscopic surgery; (6) Tumor invasion of adjacent structures such as trachea, esophagus or tissue adhesion serious; (7) Anatomical abnormalities of recurrent laryngeal nerve, such as non-recurrent larynx, were found during the operation; (8) cervical lymph node metastasis or distant metastasis; (9) Patients lost to follow-up; (10) Patients persisted in withdrawing from the trial.

Design outcomes

Primary

MeasureTime frame
Surgical data;postoperative complications;Postoperative data;Postoperative recurrence-free survival time;quality of life;VAS score;

Secondary

MeasureTime frame
Demographic and clinical characteristics of patients;

Countries

China

Contacts

Public Contactxiaowei peng

Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University.

pengxiaowei@hnca.org.cn18774055986

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026